89 results
8-K
EX-10.1
PLXPQ
PLx Pharma Winddown Corp.
26 May 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
PLXPQ
PLx Pharma Winddown Corp.
12 Apr 23
PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets
5:29pm
8-K
EX-10.5
PLXPQ
PLx Pharma Winddown Corp.
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
EX-10.3
PLXPQ
PLx Pharma Winddown Corp.
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
EX-10.4
PLXPQ
PLx Pharma Winddown Corp.
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
EX-10.1
dix5ulawmuqiq md7oq
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
EX-10.2
29pm1
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
EX-10.1
v0ytdi1je52y994v 6o
2 Mar 21
PLX Pharma Inc. Announces Proposed Public Offering of Common Stock
4:16pm
8-K
EX-10.3
iyvcw5 8p
16 Nov 20
PLx Pharma Inc. Reports Third Quarter 2020 Results and Provides Business Update
4:18pm
8-K
EX-10.2
8061wra4r672i1
16 Nov 20
PLx Pharma Inc. Reports Third Quarter 2020 Results and Provides Business Update
4:18pm
8-K
EX-10.1
u7gasjof1ygq
16 Nov 20
PLx Pharma Inc. Reports Third Quarter 2020 Results and Provides Business Update
4:18pm
8-K
EX-10.2
42m98yh2r wvgr
13 Mar 20
PLx Pharma Inc. Reports Fourth Quarter2019Results and Provides Regulatory Update on VAZALORE
7:32am
8-K
EX-10.1
o7odyp7b
13 Mar 20
PLx Pharma Inc. Reports Fourth Quarter2019Results and Provides Regulatory Update on VAZALORE
7:32am
DEFA14A
EX-10.1
9ctjohd38 tz
13 Mar 20
Additional proxy soliciting materials
7:30am
DEFA14A
EX-10.2
yzlpss wm2zdh2rdrp8
13 Mar 20
Additional proxy soliciting materials
7:30am